Selma Diagnostics ApS: Financial statements 2018
CVR: 36961376
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Selma Diagnostics ApS (CVR 36961376) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -1,662,659 and a net result of DKK -2,588,588 compared with DKK -2,251,061 the year before. Equity in the 2018 report amounted to DKK 1,513,214. The solvency ratio was 79.5%. The company had 3 employees in the financial year.
- Gross Profit
- DKK -1,662,659
- Profit/Loss
- DKK -2,588,588
- Equity
- DKK 1,513,214
- Total Assets
- DKK 1,903,824
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -1.7 mio. | -2.6 mio. | 1.5 mio. | 3 |
| 2017 | - | -1.9 mio. | -2.3 mio. | 4.1 mio. | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Selma Diagnostics ApS has published its annual report for 2017. Gross profit came to DKK -1,928,065, and the net result was DKK -2,251,061.
About Selma Diagnostics ApS
Selma Diagnostics ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Andreas Hjarne Kunding. The board consists of Carsten Krogh Gomard (chair), Andreas Hjarne Kunding and John Alexander. The company's owners include John Alexander, CARSTEN GOMARD HOLDING ApS and Selma Diagnostics ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK -1,093,508 and a net result of DKK -3,060,808 compared with DKK -2,178,400 the year before. Equity in the 2025 report amounted to DKK -11,154,823.